Persistence with tamoxifen and aromatase inhibitors in Germany: a retrospective cohort study with 284,383 patients
Niklas Gremke(Philipps University of Marburg), Matthias Kalder(Philipps University of Marburg), Ivan Nikolov(Klinikum Fulda), Saket Chaudhari(IQVIA (India)), Karel Kostev, Swati Upadhyaya(IQVIA (India)), Sebastian Griewing(Philipps University of Marburg)
Cited by 11
Related Papers
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
|Nature Communications|2020|171
Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making
|Journal of Personalized Medicine|2023|70
Evolution of publicly available large language models for complex decision-making in breast cancer care
|Archives of Gynecology and Obstetrics|2024|28
Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany
|Breast Cancer Research and Treatment|2022|19
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
|Signal Transduction and Targeted Therapy|2025|19